Mr. Ben Zadik has over 16 years of experience managing the financial operations of start-up, small-cap, and mid-sized international companies, spanning several industries and verticals. 

In addition to taking two startup companies public, Mr. Zadik led the international finance and accounting team at AMB Property Corporation, overseeing over $5 billion in global assets and managing three private equity funds in Japan, Mexico, and Canada. 

Prior to that, Mr. Zadik was a senior member of the finance team at Sangstat Medical Corporation, growing the company's revenues to over $100 Million per year and was instrumental in structuring the company's sale to Genzyme for $640 million in cash. 

Prior to that, Mr. Zadik was a senior member of the finance team at Netopia, which was acquired by Motorola for $208 million in cash. 

Presently, Mr. Zadik is a Co-Founder and the CFO and COO of Mount Tam Biotechnologies. Formed on World Lupus Day 2014, Mount Tam Biotechnologies was established to develop, optimize and bring to market leading medical compounds to improve the health and well-being of millions of people who have been affected by autoimmune diseases. The organization's first and most advanced product focuses on the treatment of lupus. Mount Tam Biotechnologies, founded by US Equity Holdings, is working extensively with the world-renowned Buck Institute for Research on Aging. It has an exclusive worldwide licensing and collaboration agreement with the Buck Institute, which includes the Institute’s most advanced R&D assets in the area of autoimmune disorders. The license contains TAM-01, a pre-IND stage compound, which represents a promising therapeutic for the treatment of systemic lupus erythematosus (SLE), the most common form of lupus. The agreement also includes other earlier-stage compounds and an extensive library of assets positioned in the autoimmune disease space. The licensed assets are supported by an extensive portfolio of intellectual property consisting of over 45 worldwide issued patents and patent applications, including composition-of-matter, manufacturing and therapeutic-area applications. 

MEMBERSHIPS

Mr. Zadik began his career with PricewaterhouseCoopers, working in both the audit and international tax practices, and is both a CPA and a Chartered Accountant (Canada).